(Q34778162)

4 August 2017

1 reference

title

Beta-adrenergic blocking drugs as antifibrillatory agents (English)

1 reference

4 August 2017

Michael J Reiter

1

1 reference

4 August 2017

1 September 2002

1 reference

Current cardiology reports

4 August 2017

1 reference

4 August 2017

4

1 reference

4 August 2017

5

1 reference

4 August 2017

426-433

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-002-0043-3

4 August 2017

0 references

cites work

Beta-blockers and sudden cardiac death.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0043-3

Physical inactivity as a risk factor for primary and secondary coronary events in Göteborg, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0043-3

Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0043-3

Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0043-3

Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0043-3

Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0043-3

Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials

21 January 2018

1 reference

12 December 2020

An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group

1 reference

12 December 2020

Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH)

1 reference

12 December 2020

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

12 December 2020

The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models

1 reference

12 December 2020

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

12 December 2020

Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group

1 reference

12 December 2020

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

12 December 2020

Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study

1 reference

12 December 2020

Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold

1 reference

12 December 2020

Beta-blocker therapy in the cardiac arrhythmia suppression trial

1 reference

12 December 2020

The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial

1 reference

12 December 2020

Influence of alpha- and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat hearts

1 reference

12 December 2020

Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring

1 reference

12 December 2020

Sudden cardiac death triggered by an earthquake

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

Effect of esmolol on the ventricular fibrillation threshold

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Importance of beta blockade in the therapy of serious ventricular arrhythmias

1 reference

12 December 2020

The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group

1 reference

12 December 2020

Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors

1 reference

12 December 2020

Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy

1 reference

12 December 2020

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

12 December 2020

Beta-blockers and heart failure: meta-analysis of mortality trials

1 reference

12 December 2020

Early intravenous beta-blockade in acute myocardial infarction

1 reference

12 December 2020

A placebo controlled evaluation of the antifibrillatory effects of carvedilol

1 reference

12 December 2020

Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group

1 reference

12 December 2020

Increased survival with beta-blockers: importance of ancillary properties

1 reference

12 December 2020

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

1 reference

12 December 2020

Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.

1 reference

12 December 2020

Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study)

1 reference

12 December 2020

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias

1 reference

12 December 2020

Bucindolol, a beta blocker, decreased ventricular fibrillation and maintained mechanical function in a pig model of acute myocardial ischemia

1 reference

12 December 2020

Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation.

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

A study of the adrenotropic receptors

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Antifibrillatory effect of esmolol alone and in combination with lidocaine.

1 reference

12 December 2020

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

1 reference

12 December 2020

Effect of carvedilol on survival in severe chronic heart failure

1 reference

12 December 2020

Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat.

1 reference

12 December 2020

Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

1 reference

12 December 2020

Prospective long-term ECG study of 100 patients surviving sudden cardiac death

1 reference

12 December 2020

The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction

1 reference

12 December 2020

Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death

1 reference

12 December 2020

10.1007/S11886-002-0043-3

Identifiers

DOI

1 reference

PubMed ID

12169240

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12169240